Literature DB >> 32211969

Predictors of Urinary Infections and Urosepsis After Ureteroscopy for Stone Disease: a Systematic Review from EAU Section of Urolithiasis (EULIS).

Shreya Chugh1, Amelia Pietropaolo1, Emanuele Montanari2, Kemal Sarica3, Bhaskar K Somani4.   

Abstract

PURPOSE OF REVIEW: To present the latest evidence related to the predictors of urinary tract infections (UTIs) and urosepsis after ureteroscopy (URS) for stone disease. RECENT
FINDINGS: Our review suggests that almost half of all post-URS complications are related to infectious complications although reported rates of urosepsis were low. The use of antibiotic prophylaxis, treatment of pre-operative UTI, and low procedural time seem to reduce this risk. However, the risk is higher in patients with higher Charlson comorbidity index, elderly patients, female gender, long duration of pre-procedural indwelling ureteric stents and patients with a neurogenic bladder and with high BMI. Infectious complications following ureteroscopy can be a source of morbidity and potential mortality. Although majority of these are minor, efforts must be taken to minimise them especially in high-risk patients. This includes the use of prophylactic antibiotics, limiting stent dwell and procedural time, prompt identification and treatment of UTI and urosepsis, and careful planning in patients with large stone burden and multiple comorbidities.

Entities:  

Keywords:  Access sheath; Antibiotic; Complication; Sepsis; Stent; UTI; Ureteroscopy; Urine culture; Urosepsis

Year:  2020        PMID: 32211969     DOI: 10.1007/s11934-020-0969-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  36 in total

1.  Outcomes of Elective Ureteroscopy for Ureteric Stones in Patients with Prior Urosepsis and Emergency Drainage: Prospective Study over 5 yr from a Tertiary Endourology Centre.

Authors:  Amelia Pietropaolo; Jane Hendry; Rena Kyriakides; Robert Geraghty; Patrick Jones; Omar Aboumarzouk; Bhaskar K Somani
Journal:  Eur Urol Focus       Date:  2018-09-13

2.  Trends in Upper Tract Stone Disease in England: Evidence from the Hospital Episodes Statistics Database.

Authors:  Nicholas J Rukin; Zain A Siddiqui; Edmund C P Chedgy; Bhaskar K Somani
Journal:  Urol Int       Date:  2016-10-01       Impact factor: 2.089

3.  Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the Clinical Research Office of the Endourological Society ureteroscopy global study.

Authors:  Enrique Perez Castro; Palle J S Osther; Viorel Jinga; Hassan Razvi; Konstantinos G Stravodimos; Kandarp Parikh; Ali R Kural; Jean J de la Rosette
Journal:  Eur Urol       Date:  2014-01-23       Impact factor: 20.096

4.  Risk Factors of Infectious Complications after Flexible Uretero-renoscopy with Laser Lithotripsy.

Authors:  Cagri Senocak; Cihat Ozcan; Tolga Sahin; Gulden Yilmaz; Ekrem Ozyuvali; Selcuk Sarikaya; Berkan Resorlu; Ural Oguz; Omer Faruk Bozkurt; Ali Unsal; Oztug Adsan
Journal:  Urol J       Date:  2018-07-10       Impact factor: 1.510

5.  Kidney stones: a global picture of prevalence, incidence, and associated risk factors.

Authors:  Victoriano Romero; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

6.  Tailoring Antibiotic Prophylaxis for Ureteroscopic Procedures Based on Local Resistance Profiles May Lead to Reduced Rates of Infections and Urosepsis.

Authors:  Ariel Zisman; Shadie Badaan; Alexander Kastin; Alexander Kravtsov; Gilad E Amiel; Michael Mullerad
Journal:  Urol Int       Date:  2019-11-19       Impact factor: 2.089

7.  Flexible Ureterorenoscopy for Renal and Proximal Ureteral Stone in Patients with Previous Ureteral Stenting: Impact on Stone-Free Rate and Morbidity.

Authors:  Jean-François Dessyn; Loïc Balssa; Eric Chabannes; Baptiste Jacquemet; Stéphane Bernardini; Hugues Bittard; Guillaume Guichard; François Kleinclauss
Journal:  J Endourol       Date:  2016-09-19       Impact factor: 2.942

8.  Unplanned Hospital Return for Infection following Ureteroscopy-Can We Identify Modifiable Risk Factors?

Authors:  Rachel A Moses; Fady M Ghali; Vernon M Pais; Elias S Hyams
Journal:  J Urol       Date:  2015-09-26       Impact factor: 7.450

9.  Analysis of Factors' Association with Risk of Postoperative Urosepsis in Patients Undergoing Ureteroscopy for Treatment of Stone Disease.

Authors:  James P Blackmur; Neil U Maitra; Rajendar R Marri; Fadi Housami; Manar Malki; Craig McIlhenny
Journal:  J Endourol       Date:  2016-07-13       Impact factor: 2.942

Review 10.  Trends of 'urolithiasis: interventions, simulation, and laser technology' over the last 16 years (2000-2015) as published in the literature (PubMed): a systematic review from European section of Uro-technology (ESUT).

Authors:  Amelia Pietropaolo; Silvia Proietti; Rob Geraghty; Andreas Skolarikos; Athanasios Papatsoris; Evangelos Liatsikos; Bhaskar K Somani
Journal:  World J Urol       Date:  2017-06-07       Impact factor: 4.226

View more
  16 in total

Review 1.  [Urolithiasis-Therapy and recurrence prevention taking into account gender-specific aspects].

Authors:  Roswitha Siener; Walter L Strohmaier; Andreas Neisius
Journal:  Urologie       Date:  2022-08-26

2.  Comprehensive Investigations of Multiple Factors That Are Related to Refractory Outcome in Urosepsis Patients.

Authors:  Takehiro Sejima; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

3.  Urolithiasis in Germany: Trends from the National DRG Database.

Authors:  Hendrik Heers; David Stay; Thomas Wiesmann; Rainer Hofmann
Journal:  Urol Int       Date:  2021-12-09       Impact factor: 1.934

4.  Clinical Observation of UreTron Single-Probe Ultrasonic Intracorporeal Lithotripter for Ureteral Calculi.

Authors:  Peng Zhang; Xiu-Wu Han; Xin Zhang; Xu-Hui Zhu; Tao Li; Yan-Sheng Li; Yuan-Hao Chen; Gao Li
Journal:  Int J Gen Med       Date:  2021-08-06

5.  Retrospective Analysis of the Risk Factors and Drug Resistance of Pathogenic Bacteria in Systemic Inflammatory Response Syndrome After Ureteroscopic Holmium Laser Lithotripsy for Impacted Ureteral Calculi.

Authors:  Quangang Yuan; Jiang Guo; Long He; Qiulin Chen; Xianhong Zou; Siming Yang; Zhenyang Zhang
Journal:  Int J Gen Med       Date:  2022-04-12

6.  Optimal timing of ureteroscopic lithotripsy after the initial drainage treatment and risk factors for postoperative febrile urinary tract infection in patients with obstructive pyelonephritis: a retrospective study.

Authors:  Yoshitaka Itami; Makito Miyake; Takuya Owari; Takashi Iwamoto; Daisuke Gotoh; Hitoshi Momose; Kiyohide Fujimoto; Shuya Hirao
Journal:  BMC Urol       Date:  2021-01-15       Impact factor: 2.264

7.  Percutaneous Nephrolithotomy Can Reduce the Incidence of Sepsis Compared with Flexible Ureteroscopy in Treating Solitary Proximal Ureteral Stone Patients with Positive Urine Culture.

Authors:  Qi-Dong Xia; Yu-Feng Wang; Chen-Qian Liu; Jin-Zhou Xu; Jian-Xuan Sun; Yang Xun; Cong Li; Jia Hu; Jun-Lin Lu; Shao-Gang Wang
Journal:  Biomed Res Int       Date:  2021-04-12       Impact factor: 3.411

Review 8.  Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review.

Authors:  Kathryn Gillams; Patrick Juliebø-Jones; Siri Øvereng Juliebø; Bhaskar K Somani
Journal:  Curr Urol Rep       Date:  2021-10-08       Impact factor: 3.092

9.  Can the Stone Scoring Systems Be Used to Predict Infective Complications of Retrograde Intrarenal Surgery?

Authors:  Samet Senel; Cuneyt Ozden; Yilmaz Aslan; Yalcin Kizilkan; Cevdet Serkan Gokkaya; Binhan Kagan Aktas
Journal:  Med Princ Pract       Date:  2022-01-19       Impact factor: 2.132

10.  Post-Ureteroscopy Infections Are Linked to Pre-Operative Stent Dwell Time over Two Months: Outcomes of Three European Endourology Centres.

Authors:  Robert M Geraghty; Amelia Pietropaolo; Luca Villa; John Fitzpatrick; Matthew Shaw; Rajan Veeratterapillay; Alistair Rogers; Eugenio Ventimiglia; Bhaskar K Somani
Journal:  J Clin Med       Date:  2022-01-09       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.